Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06377124
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-22
First Post:
2024-04-09
Brief Title:
A Smart Self-Management Support Programme 3S to Improve Quality of Life in Lung Cancer Patients
Sponsor:
The University of Hong Kong
Organization:
The University of Hong Kong
Study Overview
Official Title:
A Smart Self-Management Support Programme 3S to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lung cancers patients often experience multiple symptoms eg fatigue dyspnea distress depression sleep disturbance The current study attempts to explore the efficacy of the Smart Self-Management Support Programme 3S in improving quality of life of patients using self-management support programme with mobile devices
Detailed Description:
Lung cancer LC is the most and second most common cancer globally and locally respectively LC patients often experience multiple symptoms eg fatigue dyspnea distress depression sleep disturbance The symptom burden is greater than other cancers and adversely affects quality of life Care of LC patients has shifted from a purely disease-centered approach on survival-related outcomes to person-centered approach with emphasis on quality-of-life outcomes
Self-management support programme SMS is perceived to supplement regular medical treatments and follow-up and cost-effective in cancer care Besides digital technologies have been used in patient empowerment digital platform to improve self-management of cancer patients Using the self-management support programme and mobile devices the Smart Self-Management Support Programme 3S attempts to improve quality of life of patients
The current study aims to examine the efficacy of 3S on improving quality of life and patient activation knowledge skills and confidence for self-management in the 3S intervention group compared to the general health GH control group It also aims to examine the changes in the burden of care anxiety and depression symptoms and quality of life of the family caregivers FCGs of the patients in the 3S group compared to FCGs of the patients in the GH group
We also conduct process valuations to assess the essential features of context implementation and impact mechanism and cost-effectiveness evaluation to examine health care resource utilisation and cost-effectiveness analysis
160 patients with lung cancer will be recruited and 160 family caregivers will also be invited to join the study
Self-management support programme SMS is perceived to supplement regular medical treatments and follow-up and cost-effective in cancer care Besides digital technologies have been used in patient empowerment digital platform to improve self-management of cancer patients Using the self-management support programme and mobile devices the Smart Self-Management Support Programme 3S attempts to improve quality of life of patients
The current study aims to examine the efficacy of 3S on improving quality of life and patient activation knowledge skills and confidence for self-management in the 3S intervention group compared to the general health GH control group It also aims to examine the changes in the burden of care anxiety and depression symptoms and quality of life of the family caregivers FCGs of the patients in the 3S group compared to FCGs of the patients in the GH group
We also conduct process valuations to assess the essential features of context implementation and impact mechanism and cost-effectiveness evaluation to examine health care resource utilisation and cost-effectiveness analysis
160 patients with lung cancer will be recruited and 160 family caregivers will also be invited to join the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None